The Pharmaceutical Industry’s Salvation, or Impediments to Future Innovation?
Specialty products came onto the scene in dramatic fashion in 2010 and they have delivered strong growth in the years since. This trend is forcing payers to aggressively manage their budgets in ways that are unfortunately dampening revenues for specialty brand manufacturers.
The Launch Excellence team conducted an analysis to quantify the full impact of launches pre- and post-hepatitis C era. Findings showed that the differential between innovative brands and non-innovative brands is diminishing at an alarming rate.
Read more to inform your launch strategies.